Logo image of VRAR

GLIMPSE GROUP INC/THE (VRAR) Stock Fundamental Analysis

NASDAQ:VRAR - Nasdaq - US37892C1062 - Common Stock - Currency: USD

1.34  +0.04 (+3.08%)

Fundamental Rating

3

Taking everything into account, VRAR scores 3 out of 10 in our fundamental rating. VRAR was compared to 81 industry peers in the IT Services industry. While VRAR seems to be doing ok healthwise, there are quite some concerns on its profitability. VRAR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VRAR had negative earnings in the past year.
In the past year VRAR has reported a negative cash flow from operations.
VRAR had negative earnings in each of the past 5 years.
VRAR had a negative operating cash flow in each of the past 5 years.
VRAR Yearly Net Income VS EBIT VS OCF VS FCFVRAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

Looking at the Return On Assets, with a value of -32.03%, VRAR is doing worse than 87.65% of the companies in the same industry.
Looking at the Return On Equity, with a value of -38.77%, VRAR is doing worse than 72.84% of the companies in the same industry.
Industry RankSector Rank
ROA -32.03%
ROE -38.77%
ROIC N/A
ROA(3y)-58.09%
ROA(5y)-122.58%
ROE(3y)-110.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VRAR Yearly ROA, ROE, ROICVRAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

With an excellent Gross Margin value of 70.35%, VRAR belongs to the best of the industry, outperforming 87.65% of the companies in the same industry.
In the last couple of years the Gross Margin of VRAR has grown nicely.
VRAR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y3.11%
VRAR Yearly Profit, Operating, Gross MarginsVRAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

6

2. Health

2.1 Basic Checks

VRAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRAR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VRAR has more shares outstanding
There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRAR Yearly Shares OutstandingVRAR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
VRAR Yearly Total Debt VS Total AssetsVRAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that VRAR is in the distress zone and has some risk of bankruptcy.
VRAR has a worse Altman-Z score (0.15) than 82.72% of its industry peers.
There is no outstanding debt for VRAR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACCN/A
WACC9.24%
VRAR Yearly LT Debt VS Equity VS FCFVRAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 2.57 indicates that VRAR has no problem at all paying its short term obligations.
VRAR has a better Current ratio (2.57) than 76.54% of its industry peers.
VRAR has a Quick Ratio of 2.57. This indicates that VRAR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of VRAR (2.57) is better than 76.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 2.57
VRAR Yearly Current Assets VS Current LiabilitesVRAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 86.71% over the past year.
The Revenue for VRAR has decreased by -12.32% in the past year. This is quite bad
The Revenue has been growing by 55.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)86.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-12.32%
Revenue growth 3Y37.05%
Revenue growth 5Y55.13%
Sales Q2Q%-24.97%

3.2 Future

Based on estimates for the next years, VRAR will show a very strong growth in Earnings Per Share. The EPS will grow by 37.30% on average per year.
The Revenue is expected to grow by 14.83% on average over the next years. This is quite good.
EPS Next Y77.01%
EPS Next 2Y37.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.1%
Revenue Next 2Y14.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
VRAR Yearly Revenue VS EstimatesVRAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
VRAR Yearly EPS VS EstimatesVRAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VRAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VRAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRAR Price Earnings VS Forward Price EarningsVRAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRAR Per share dataVRAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

VRAR's earnings are expected to grow with 37.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.3%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VRAR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLIMPSE GROUP INC/THE

NASDAQ:VRAR (6/30/2025, 12:35:05 PM)

1.34

+0.04 (+3.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners14.55%
Inst Owner Change-20.6%
Ins Owners14.98%
Ins Owner Change0%
Market Cap28.22M
Analysts82.86
Price Target2.67 (99.25%)
Short Float %1.57%
Short Ratio1.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-66.67%
Min EPS beat(2)-243.14%
Max EPS beat(2)109.8%
EPS beat(4)2
Avg EPS beat(4)-34.4%
Min EPS beat(4)-243.14%
Max EPS beat(4)109.8%
EPS beat(8)5
Avg EPS beat(8)-110.65%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.41%
Min Revenue beat(2)-7.04%
Max Revenue beat(2)0.22%
Revenue beat(4)1
Avg Revenue beat(4)-7.56%
Min Revenue beat(4)-15.33%
Max Revenue beat(4)0.22%
Revenue beat(8)3
Avg Revenue beat(8)-1.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-43.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-350%
EPS NY rev (1m)0%
EPS NY rev (3m)-700%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-46.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.22
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 4.94
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.42
BVpS0.79
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.03%
ROE -38.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.35%
FCFM N/A
ROA(3y)-58.09%
ROA(5y)-122.58%
ROE(3y)-110.23%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.13%
GM growth 5Y3.11%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.55%
Cap/Sales 0.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 2.57
Altman-Z 0.15
F-Score5
WACC9.24%
ROIC/WACCN/A
Cap/Depr(3y)15.4%
Cap/Depr(5y)59.24%
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y77.01%
EPS Next 2Y37.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.32%
Revenue growth 3Y37.05%
Revenue growth 5Y55.13%
Sales Q2Q%-24.97%
Revenue Next Year1.1%
Revenue Next 2Y14.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.11%
OCF growth 3YN/A
OCF growth 5YN/A